WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma

Phase 1

Withdrawn

Conditions: Melanoma

Interventions: Biological: dactinomycin
Drug: melphalan
Biological: Conditionally replicative adenovirus 3/5-delta

First Posted Date: 2012-02-10

Last Posted Date: 2014-07-18

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT01531244

Safety and Metabolic Study of Highly Active Antiretroviral Therapy (HAART) in Malnourished Children With HIV

Completed

Conditions: HIV
Marasmus
Severe Acute Malnutrition
Kwashiorkor

Interventions: Drug: zidovudine, lamivudine, nevirapine

First Posted Date: 2012-02-08

Last Posted Date: 2014-01-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 42

Registration Number: NCT01529125

Locations: 🇲🇼
Queen Elizabeth Central Hospital, Blantyre, Malawi

Medtronic Reveal XT Study

Phase 2

Completed

Conditions: Atrial Fibrillation

Interventions: Device: Reveal XT implantation

First Posted Date: 2012-02-03

Last Posted Date: 2017-08-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 47

Registration Number: NCT01526343

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma

Phase 1

Terminated

Conditions: Cholangiocarcinoma
Liver Neoplasms

Interventions: Drug: Floxuridine
Drug: Dexamethasone
Drug: Gemcitabine
Drug: Oxaliplatin

First Posted Date: 2012-02-02

Last Posted Date: 2022-08-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 27

Registration Number: NCT01525069

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite

Phase 2

Withdrawn

Conditions: Anorexia

Interventions: Drug: Megestrol Acetate
Drug: Mirtazapine

First Posted Date: 2011-12-29

Last Posted Date: 2014-02-03

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT01501396

Photoacoustic Endoscopy in Endometrial Cancer

Early Phase 1

Withdrawn

Conditions: Endometrial Cancer
Benign Neoplasm of Body of Uterus

Interventions: Device: Photoacoustic endoprobe
Procedure: Photoacoustic endoscopy

First Posted Date: 2011-12-23

Last Posted Date: 2013-07-11

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT01498237

Azithromycin to Prevent Wheezing Following Severe Respiratory Syncytial Virus (RSV) Bronchiolitis

Phase 2

Completed

Conditions: RSV Bronchiolitis

Interventions: Drug: Azithromycin
Drug: Placebo

First Posted Date: 2011-12-06

Last Posted Date: 2017-06-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT01486758

Locations: 🇺🇸
Department of Pediatrics, Washington University School of Medicine; and St. Louis Children's Hospital, Saint Louis, Missouri, United States

PET Imaging in Patients at Risk for Acute Lung Injury

Completed

Conditions: Early Pulmonary Neutrophilic Inflammation
Acute Lung Injury

Interventions: Radiation: PET-CT scan

First Posted Date: 2011-12-06

Last Posted Date: 2013-01-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 5

Registration Number: NCT01486342

Locations: 🇺🇸
Washington University in St. Louis School of Medicine, St. Louis, Missouri, United States

Computerized Contraceptive Decision Aid

Not Applicable

Completed

Conditions: Decision Making
Satisfaction
Contraception
Evaluation

Interventions: Other: CDM Tool

First Posted Date: 2011-11-28

Last Posted Date: 2020-09-29

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 253

Registration Number: NCT01479985

Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors

Phase 1

Terminated

Conditions: Carcinoma
Sarcoma
Lymphoma

Interventions: Drug: 64Cu-DOTA-U3-1287
Drug: U3-1287 (unlabeled)

First Posted Date: 2011-11-24

Last Posted Date: 2013-12-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 12

Registration Number: NCT01479023

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy